Cemiplimab in Ultra-Octogenarian Patients with Cutaneous Squamous Cell Carcinoma: The Real-Life Experience of a Tertiary Referral Center

Cemiplimab in Ultra-Octogenarian Patients with Cutaneous Squamous Cell Carcinoma: The Real-Life Experience of a Tertiary Referral Center

Background: The incidence of cutaneous squamous cell carcinoma (cSCC) is rapidly increasing, paralleling the aging of the population. cSCC predominantly affects chronically sun-exposed areas, such as the head and neck region. At our tertiary center, a multidisciplinary approach to non-melanoma skin...

Full description

Bibliographic Details
Main Authors: Nerina Denaro, Emanuela Passoni, Alice Indini, Gianluca Nazzaro, Giada Anna Beltramini, Valentina Benzecry, Giuseppe Colombo, Carolina Cauchi, Cinzia Solinas, Mario Scartozzi, Angelo Valerio Marzano, Ornella Garrone
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Vaccines
Subjects:
ultra-octogenarian
cutaneous squamous cell carcinoma
Cemiplimab
immunotherapy
geriatric oncology
Online Access:https://www.mdpi.com/2076-393X/11/9/1500

Similar Items

Similar Items